過去の関連発表

Wang F, Murata T, Izumi N, Kida M, Horblyuk R, Terayama Y. Bleeding risk among Japanese non-valvular atrial fibrillation patients initiated on Apixaban, Dabigatran, Rivaroxaban or Warfarin in the real world. American College of Cardiology. March 18, 2017.

Wang F, Murata T, Izumi N, Kida M, Horblyuk R, Terayama Y. Bleeding risk among Japanese non-valvular atrial fibrillation patients initiated on Apixaban, Dabigatran, Rivaroxaban or Warfarin in the real world. American College of Cardiology. March 18, 2017.